Development of α-Tocopherol Acetate Nanoparticles: Influence of Preparative Processes
暂无分享,去创建一个
A. Lorino | H. Fessi | A. Astier | N. Razzouq | M. Paul | C. Fernandez | M. Carvalho | J. Anais
[1] S. Antimisiaris,et al. Liposomes for drug delivery to the lungs by nebulization. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[2] V. Castranova,et al. Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice. , 2007, Toxicology and applied pharmacology.
[3] P. Rouxhet,et al. Aerosolization properties, surface composition and physical state of spray-dried protein powders. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[4] J. Hanes,et al. Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[5] E. Perrier,et al. Synthesis and characterization of polyurethane and poly(ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsification. , 2004, International journal of pharmaceutics.
[6] W. Seeger,et al. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[7] J. Hanes,et al. New polymeric carriers for controlled drug delivery following inhalation or injection. , 2002, Biomaterials.
[8] A. Orecchioni,et al. α-Tocopherol encapsulation and in vitro release from wheat gliadin nanoparticles , 2002, Journal of microencapsulation.
[9] K. Panda,et al. Vitamin C prevents cigarette smoke induced oxidative damage of proteins and increased proteolysis. , 1999, Free radical biology & medicine.
[10] S. Shapiro,et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.
[11] P. Couvreur,et al. On shelf stability of freeze-dried poly(methylidene malonate 2.1.2) nanoparticles , 1997 .
[12] Hatem Fessi,et al. Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique , 1996 .
[13] G. Atlan,et al. Pulmonary clearance and lung function: influence of acute tobacco intoxication and of vitamin E. , 1996, Journal of applied physiology.
[14] O.N.M. Mc Callion,et al. Nebulisation of monodisperse latex sphere suspensions in air-jet and ultrasonic nebulisers , 1996 .
[15] P. Shek,et al. Intratracheally administered liposomal alpha-tocopherol protects the lung against long-term toxic effects of paraquat. , 1995, Biomedical and environmental sciences : BES.
[16] J. Benoit,et al. In vitro study of the anti-leishmanial activity of biodegradable nanoparticles. , 1995, Journal of drug targeting.
[17] P. Shek,et al. Prevention of phorbol myristate acetate-induced acute lung injury by alpha-tocopherol liposomes. , 1995, Journal of drug targeting.
[18] A. Taburet,et al. Pharmacokinetic Optimisation of Asthma Treatment , 1994, Clinical pharmacokinetics.
[19] M. Davies,et al. The preparation of sub-200 nm biodegradable colloidal particles from poly(β-malic acid-co-benzyl malate) copolymers and their surface modification with Poloxamer and Poloxamine surfactants , 1994 .
[20] P. Shek,et al. Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery. , 1994, Journal of drug targeting.
[21] H. Schreier,et al. Pulmonary delivery of liposomes , 1993 .
[22] M. Nakakura,et al. Blood clearance and tissue distribution of various formulations of alpha-tocopherol injection after intravenous administration. , 1993, Chemical & pharmaceutical bulletin.
[23] K. Fukuzawa,et al. Location, Antioxidant and Recycling Dynamics of α -Tocopherol in Liposome Membranes , 1993 .
[24] P. Shek,et al. Protective effect of liposome-associated alpha-tocopherol against paraquat-induced acute lung toxicity. , 1992, Biochemical pharmacology.
[25] P. Wollmer,et al. Integrity of the alveolar-capillary barrier and alveolar surfactant system in smokers. , 1992, Thorax.
[26] R. Jalil,et al. Microencapsulation using poly (L-lactic acid) II: Preparative variables affecting microcapsule properties. , 1990, Journal of microencapsulation.
[27] C. Johnson. Principles of nebulizer-delivered drug therapy for asthma. , 1989, American journal of hospital pharmacy.
[28] D. Cornwell,et al. Deficiency of vitamin E in the alveolar fluid of cigarette smokers. Influence on alveolar macrophage cytotoxicity. , 1986, The Journal of clinical investigation.
[29] C. Chow,et al. Dietary vitamin E and pulmonary biochemical responses of rats to cigarette smoking. , 1984, Environmental research.
[30] M. Newhouse. UFFI dust: nonspecific irritant only? , 1982, Chest.
[31] B. E. Walker,et al. INTAKE AND ABSORPTION OF TOCOPHEROL * , 1972, Annals of the New York Academy of Sciences.